Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense
Public ClinicalTrials.gov record NCT06993610. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multi-Center Study Consisting of a Randomized, Placebo-Controlled Period, Followed by an Open-Label Extension Period to Assess the Efficacy, Safety, and Tolerability of Tibulizumab in Adults With Hidradenitis Suppurativa
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study is a Phase 2, multi-center, randomized, double-blind, placebo-controlled study to evaluate the effects of tibulizumab over 16 weeks (Period 1) in adults with hidradenitis suppurativa, followed by a 16-week open-label extension period in which all participants will receive tibulizumab (Period 2)
Study identification
- NCT ID
- NCT06993610
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 247 participants
Conditions and interventions
Conditions
Interventions
- Tibulizumab Dose A Biological
- Tibulizumab Dose B Biological
- Placebo Other
Biological · Other
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 16, 2025 (Actual)
- Primary completion
- Sep 18, 2026 (Actual)
- Completion
- Apr 2027 (Estimated)
- Last update posted
- Oct 19, 2026
2025 – 2027
United States locations
- U.S. sites
- 34
- U.S. states
- 18
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Medical Dermatology Specialists (Phoenix) | Phoenix | Arizona | 85006 | — |
| First OC Dermatology Research, Inc. | Irvine | California | 92614 | — |
| Wallace Medical Group, Inc. | Los Angeles | California | 90056 | — |
| Northridge Clinical Trials | Northridge | California | 91325 | — |
| NorCal Clinical Research | Rocklin | California | 95765 | — |
| Florida Academic Dermatology Center | Coral Gables | Florida | 33134 | — |
| Skin Care Research, LLC | Hollywood | Florida | 33021 | — |
| Georgia Skin & Cancer Clinic | Savannah | Georgia | 31419 | — |
| Indiana University School of Medicine | Indianapolis | Indiana | 46202 | — |
| The Indiana Clinical Trials Center | Plainfield | Indiana | 46168 | — |
| Equity Medical LLC (Kentucky) | Bowling Green | Kentucky | 42104 | — |
| DS Research of Kentucky, LLC | Louisville | Kentucky | 40241 | — |
| DelRicht LLC | Baton Rouge | Louisiana | 70809 | — |
| Clinical Trials Management, LLC | Metairie | Louisiana | 70006 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| MediSearch Clinical Trials | Saint Joseph | Missouri | 64506 | — |
| Skin Cancer and Dermatology Institute | Reno | Nevada | 89509 | — |
| Equity Medical | New York | New York | 10023 | — |
| OptiSkin Medical | New York | New York | 10128 | — |
| Red River Research Partners | Fargo | North Dakota | 58103 | — |
| Optima Research | Boardman | Ohio | 44512 | — |
| ClinOhio Research Services | Columbus | Ohio | 43213 | — |
| Apex Clinical Research Center | Mayfield Heights | Ohio | 44124 | — |
| Best Skin Research LLC | Camp Hill | Pennsylvania | 17011 | — |
| Palmetto Clinical Trial Services | Anderson | South Carolina | 29625 | — |
| DelRicht Research | Mt. Pleasant | South Carolina | 29464 | — |
| International Clinical Research - Tennessee LLC | Murfreesboro | Tennessee | 37130 | — |
| Dermatology Treatment and Research Center | Dallas | Texas | 75230 | — |
| BRCR Global Texas | Katy | Texas | 77450 | — |
| DelRicht Research | Prosper | Texas | 75078 | — |
| Progressive Clinical Research | San Antonio | Texas | 78213 | — |
| Frontier Dermatology | Mill Creek | Washington | 98012 | — |
| University of Washington Medical Center | Seattle | Washington | 98164 | — |
| Dermatology Specialists of Spokane | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06993610, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 19, 2026 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06993610 live on ClinicalTrials.gov.